Hidden complexities in the measurement of fructosyl-lysine and advanced glycation end products for risk prediction of vascular complications of diabetes

Diabetes

Volumn 64, Issue 1, 2015, Pages 9-11

  Rabbani, Naila ^a   Thornalley, Paul J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRUCTOSAMINE; FRUCTOSYLLYSINE; GLUCOSE; LYSINE; METHYLGLYOXAL; UNCLASSIFIED DRUG;

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE DILUTION ASSAY; KIDNEY CLEARANCE; LIQUID CHROMATOGRAPHY; MEMBRANE PERMEABILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PROTEIN GLYCOSYLATION; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; BLOOD; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; MALE; METABOLISM;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE;

EID: 84920000582     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1516     Document Type: Note

References (20)

1. Rabbani N, Thornalley PJ. Glycation research in amino acids: A place to call home. Amino Acids 2012;42:1087-1096
2. Thornalley PJ, Rabbani N. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry-A user's perspective. Biochim Biophys Acta 2014;1840:8182829
3. Zhang X, Frischmann M, Kientsch-Engel R, et al. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients. Clin Chem Lab Med 2005;43:503-511
4. Wang F, Zhao Y, Niu Y, et al. Activated glucose-6-phosphate dehydrogenase is associated with insulin resistance by upregulating pentose and pentosidine in diet-induced obesity of rats. Horm Metab Res 2012;44:938-942
5. Nathan DM, McGee P, Steffes MW, Lachin JM, Grp DER; DCCT/EDIC Research Group. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes 2014;63:282-290
6. Rabbani N, Xue M, Thornalley PJ. Activity, regulation, copy number and function in the glyoxalase system. Biochem Soc Trans 2014;42:419-424
7. Zhang Z, Yang Z, Zhu B, et al. Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose. PLoS One 2012;7:e49128
8. Hanssen NMJ, Beulens JWJ, van Dieren S, et al. Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: A case-cohort study with a median follow-up of 10 years (EPIC-NL). Diabetes 2015;64:2572265
9. Genuth S, Sun W, Cleary P, et al.; The DCCT/EDIC Research Group. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. Diabetes 2015;64:2662278
10. Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia 2005;48:1590-1603
11. Dell'Omo G, Penno G, Pucci L, Mariani M, Del Prato S, Pedrinelli R. Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid metabolic syndrome. Atherosclerosis 2004;172:383-389
12. Kornerup K, Nordestgaard BG, Jensen TK, et al. Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis. Cardiovasc Res 2004;64:337-345
13. Rabbani N, Adaikalakoteswari A, Rossing K, et al. Effect of irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria. Amino Acids 2012;42:1627-1639
14. Dell'Omo G, Bandinelli S, Penno G, Pedrinelli R, Mariani M. Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin Pharmacol Ther 2000;68:427-434
15. Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, Deckert T. Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987;30:2-4
16. Mäkinen V-P, Civelek M, Meng Q, et al.; Coronary ARtery DIsease Genome- Wide Replication And Meta-Analysis (CARDIoGRAM) Consortium. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet 2014;10:e1004502
17. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993;91:2463-2469
18. Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW. Decrease in skin collagen glycation with improved glycemic control in patients with insulindependent diabetes mellitus. J Clin Invest 1991;87:1910-1915
19. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond) 1994;87:21-29
20. Bierhaus A, Fleming T, Stoyanov S, et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy [published correction appears in Nat Med. 2012;18:1445]. Nat Med 2012;18:926-933